Cutler Group LP Bluebird Bio, Inc. Transaction History

Cutler Group LP

$307 Million
Q1 2024

A detailed history of Cutler Group LP transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Cutler Group LP holds 800 shares of BLUE stock, worth $7,936. This represents 0.0% of its overall portfolio holdings.

Number of Shares

800

Previous 800 -0.0%

Holding current value

$7,936

Previous $1,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 18, 2024	BUY	$1.32 - $4.83 $1,056 - $3,864	800 New	800 $1,000
Q4 2022 Feb 07, 2023	SELL	$5.77 - $8.49 $5,770 - $8,490	-1,000 Reduced 11.55%	7,656 $52,000
Q3 2022 Oct 25, 2022	SELL	$3.75 - $7.39 $22,623 - $44,583	-6,033 Reduced 41.07%	8,656 $54,000
Q2 2022 Aug 04, 2022	BUY	$2.94 - $5.23 $32,548 - $57,901	11,071 Added 306.0%	14,689 $60,000
Q3 2021 Oct 26, 2021	BUY	$11.24 - $21.0 $38,081 - $71,148	3,388 Added 1473.04%	3,618 $69,000
Q2 2020 Jul 22, 2020	SELL	$27.12 - $45.97 $26,306 - $44,590	-970 Reduced 80.83%	230 $14,000
Q1 2020 May 07, 2020	SELL	$26.16 - $63.5 $162,192 - $393,700	-6,200 Reduced 83.78%	1,200 $55,000
Q2 2019 Aug 09, 2019	BUY	$75.84 - $105.21 $295,776 - $410,319	3,900 Added 111.43%	7,400 $941,000
Q1 2019 May 10, 2019	SELL	$64.44 - $104.11 $70,884 - $114,521	-1,100 Reduced 23.91%	3,500 $550,000
Q3 2018 Nov 07, 2018	SELL	$88.86 - $117.49 $395,427 - $522,830	-4,450 Reduced 49.17%	4,600 $671,000
Q2 2018 Aug 10, 2018	BUY	$99.64 - $127.59 $229,172 - $293,457	2,300 Added 34.07%	9,050 $1.42 Million
Q1 2018 May 11, 2018	SELL	$105.8 - $150.94 $608,455 - $868,055	-5,751 Reduced 46.0%	6,750 $1.15 Million
Q4 2017 Jan 17, 2018	BUY	$81.25 - $130.7 $764,887 - $1.23 Million	9,414 Added 304.96%	12,501 $2.23 Million
Q3 2017 Oct 17, 2017	BUY	$57.74 - $91.42 $178,243 - $282,213	3,087	3,087 $423,000

Others Institutions Holding BLUE

# of Institutions

150

Shares Held

63.4M

Call Options Held

264K

Put Options Held

428K

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $765M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account